Sarah Venis: Debating evidence and innovation in humanitarian assistance—a conference without borders

How strong is the evidence base underlying humanitarian medical assistance? How do you innovate safely to overcome the obstacles inherent in delivering care in conflict settings or to regions where no direct access to the population is possible, such as the besieged areas of Syria? Every year, Médecins Sans Frontières (MSF) attempts to answer some […]

Read More…

Leonardo Palumbo: Shorter regimens offer new hope to adults and children with MDR TB by halving treatment time

Recent treatment regimens for drug-resistant tuberculosis (DR-TB) have resulted in patients enduring a gruelling two-year treatment journey, which necessitates taking up to 20 tablets every day with months of daily painful injections. The side-effects associated with the treatment results in many suffering from permanent hearing loss and some developing suicidal depression and psychosis. For those […]

Read More…

Vickie Hawkins: “Your enemy’s doctor is not your enemy. Hospitals are not targets”

Late on Wednesday night two barrel bombs fell on buildings surrounding the hospital of Al Quds hospital in Aleppo, Northern Syria. As tens of wounded were being rushed to the emergency room (ER) for treatment, a third barrel bomb fell directly at the entrance to the ER, killing and injuring staff and patients. The building […]

Read More…

Jay Achar: Drug resistant tuberculosis—not just a precursor to the post-antibiotic apocalypse

In 2015 the world woke up to the idea that the spread of antimicrobial resistance (AMR) will ultimately lead to a post-antibiotic era in which even simple medical treatments will cease to be possible. Over the past decade the infectious disease medical community has looked on in horror as NDM-1 (New Delhi metallo-beta-lactamase-1—an enzyme rendering […]

Read More…

Grania Brigden: Step up to stop TB

Grania Brigden discusses the findings of the Out of Step report on national tuberculosis (TB) policies. The report is being launched on 2 December at the 46th Union World Conference on Lung Health, Cape Town, South Africa. TB is winning a deadly race—this year it overtook HIV as the world’s deadliest infectious disease, killing 1.5 million people […]

Read More…

Helen Bygrave: More people, more time, better data—what we need to “treat all” with HIV

On World AIDS Day and with the ICASA conference ongoing, Helen Bygrave discusses the implications of the recently announced World Health Organization (WHO) “treat all” policy. On the back of the headline studies Temprano, START, and new data from HPTN 052, the WHO recently announced the “treat all” policy: everyone diagnosed with HIV should start […]

Read More…

Helen Bygrave: Simple but elusive—why are we still talking about HIV drug delivery?

As the International AIDS Society (IAS) Conference takes place in Vancouver, Canada (July 19-22), Helen Bygrave of MSF discusses her frustrations with the lack of implementation of simple, programmatic strategies for improving HIV care. My main memory of the last IAS conference that I attended, held in Vienna in 2010, was a resounding standing ovation for a […]

Read More…